Payment overview · 2025
General Payments
$230.25
6 reported records · 1 companies
Healthcare provider profile · identity verified
John Bradley Morris, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SANDY, UT · NPI 1295171247
Verified facts
What the public records show
CMS Open Payments records show John Bradley Morris, MD received $230.25 in general payments during 2025 across 6 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $230.25 | 100.0% | 6 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $230.25 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $99.46 | 1 | 2025 |
Source payment records
|
|||||
| SpyGlass Normalized: spyglass |
Device | Boston Scientific Corporation | $93.12 | 1 | 2025 |
Source payment records
|
|||||
| Axios Normalized: axios |
Device | Boston Scientific Corporation | $16.14 | 2 | 2025 |
Source payment records
|
|||||
| General - Biliary Devices Normalized: general biliary devices |
Device | Boston Scientific Corporation | $11.84 | 1 | 2025 |
Source payment records
|
|||||
| EXALT Model D Normalized: exalt model d |
Device | Boston Scientific Corporation | $9.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1212 | 358 |
| Omeprazole | Omeprazole | 675 | 238 |
| Levothyroxine Sodium | Levothyroxine Sodium | 582 | 168 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 397 | 126 |
| Metformin Hcl | Metformin Hcl | 386 | 116 |
| Amlodipine Besylate | Amlodipine Besylate | 361 | 120 |
| Celecoxib | Celecoxib | 359 | 160 |
| Tamsulosin Hcl | Tamsulosin Hcl | 353 | 112 |
| Losartan Potassium | Losartan Potassium | 324 | 112 |
| Metformin Hcl Er | Metformin Hcl | 310 | 113 |
| Gabapentin | Gabapentin | 298 | 101 |
| Meloxicam | Meloxicam | 279 | 121 |
| Eliquis | Apixaban | 269 | 68 |
| Simvastatin | Simvastatin | 251 | 79 |
| Trazodone Hcl | Trazodone Hcl | 240 | 76 |
| Furosemide | Furosemide | 228 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 221 | 73 |
| Potassium Chloride | Potassium Chloride | 221 | 71 |
| Finasteride | Finasteride | 220 | 74 |
| Irbesartan | Irbesartan | 217 | 67 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 209 | 66 |
| Sertraline Hcl | Sertraline Hcl | 208 | 66 |
| Carvedilol | Carvedilol | 202 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 199 | 63 |
| Lisinopril | Lisinopril | 196 | 62 |
| Pravastatin Sodium | Pravastatin Sodium | 182 | 56 |
| Alendronate Sodium | Alendronate Sodium | 166 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 156 | 57 |
| Spironolactone | Spironolactone | 152 | 53 |
| Allopurinol | Allopurinol | 151 | 45 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 151 | 49 |
| Propranolol Hcl Er | Propranolol Hcl | 133 | 42 |
| Glipizide | Glipizide | 127 | 44 |
| Fluoxetine Hcl | Fluoxetine Hcl | 118 | 38 |
| Pregabalin | Pregabalin | 116 | 37 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 115 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 114 | 69 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 114 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 114 | 46 |
| Donepezil Hcl | Donepezil Hcl | 105 | 39 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 103 | 63 |
| Mirtazapine | Mirtazapine | 100 | 43 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 97 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 96 | 35 |
| Tramadol Hcl | Tramadol Hcl | 95 | 30 |
| Jardiance | Empagliflozin | 91 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 90 | 27 |
| Valsartan | Valsartan | 87 | 26 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 79 | 30 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 70 | 25 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 69 | 23 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 65 | 22 |
| Glipizide Er | Glipizide | 65 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 47 |
| Alprazolam | Alprazolam | 64 | 25 |
| Prednisone | Prednisone | 64 | 37 |
| Topiramate | Topiramate | 64 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 62 | 19 |
| Ezetimibe | Ezetimibe | 62 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 59 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 59 | 15 |
| Montelukast Sodium | Montelukast Sodium | 58 | 19 |
| Bupropion Hcl Sr | Bupropion Hcl | 57 | 22 |
| Bupropion Xl | Bupropion Hcl | 56 | 20 |
| Myrbetriq | Mirabegron | 54 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 53 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 50 | 17 |
| Solifenacin Succinate | Solifenacin Succinate | 49 | 25 |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 47 | 13 |
| Buspirone Hcl | Buspirone Hcl | 46 | 16 |
| Estradiol | Estradiol | 46 | 17 |
| Warfarin Sodium | Warfarin Sodium | 46 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 14 |
| Propranolol Hcl | Propranolol Hcl | 43 | 17 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 40 | 14 |
| Trulicity | Dulaglutide | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 19 |
| Ozempic | Semaglutide | 37 | suppressed |
| Torsemide | Torsemide | 37 | 15 |
| Clonazepam | Clonazepam | 36 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | 12 |
| Ibuprofen | Ibuprofen | 35 | 13 |
| Famotidine | Famotidine | 34 | 14 |
| Cephalexin | Cephalexin | 32 | 28 |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Glimepiride | Glimepiride | 31 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | 14 |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 15 |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 28 | 24 |
| Ipratropium Bromide | Ipratropium Bromide | 27 | 11 |
| Lovastatin | Lovastatin | 27 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 27 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 26 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 21 |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 17 |
| Eplerenone | Eplerenone | 24 | suppressed |
| Naproxen | Naproxen | 24 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Azithromycin | Azithromycin | 17 | 13 |
| Calcitriol | Calcitriol | 17 | suppressed |
| Indapamide | Indapamide | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 16 | suppressed |
| Lorazepam | Lorazepam | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Repatha Syringe | Evolocumab | 15 | suppressed |
| Testosterone | Testosterone | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 12 |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 13 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 13 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Probenecid-Colchicine | Probenecid/Colchicine | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | 11 |
| Mercaptopurine | Mercaptopurine | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $230.25 · 6 records | Boston Scientific Corporation | Axios, EXALT Model D, General - Biliary Devices, General - Therapies, SpyGlass | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error